HOME >> MEDICINE >> NEWS
UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded a UCLA research team a five-year, $9 million contract to fund a multicenter study investigating antibiotic treatments for MRSA, a staph infection seen increasingly in communities across the nation that is resistant to antibiotics most commonly used to treat skin infections.

The study, to be led by co-principal investigators Dr. David A. Talan and Dr. Gregory J. Moran, both of Olive ViewUCLA Medical Center and the David Geffen School of Medicine at UCLA, will explore whether various off-patent antibiotics for the treatment of uncomplicated skin and soft tissue infections may be effective in treating MRSA, or methicillin-resistant Staphylococcus aureus. Off-patent medications are those whose patents have expired, allowing any manufacturer to produce them.

The emergence of the new, potentially more infectious and virulent strain of S. aureus in the community, referred to as community-associated or CAMRSA, has caused serious outbreaks of disease over the past few years, said Talan, a professor of medicine at the Geffen School of Medicine and chief of emergency medicine and professor of infectious diseases at Olive ViewUCLA. We are hopeful to be able to identify the most effective antibiotic treatment for these infections.

Last year, the research team reported in The New England Journal of Medicine that CA-MRSA had become the most common cause of skin and soft tissue infections among patients presenting to a geographically diverse group of 11 emergency departments across the nation. Researchers tested MRSA resistance to antibiotics in a test tube and found that in 57 percent of cases, doctors had prescribed an antibiotic to which the bacteria were resistant. Finding certain antibiotics ineffective against MRSA in a laboratory setting, however, does not necessarily mean they will fail in patients, who have the help of thei
'"/>

Contact: Rachel Champeau
rchampeau@mednet.ucla.edu
310-794-0777
University of California - Los Angeles
9-Aug-2007


Page: 1 2

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. Penn researchers discover novel pathway for increasing good cholesterol
3. Theory of facial aging gets a facelift from UT Southwestern researchers
4. UIC researchers to develop new drugs to fight bioterrorism
5. UQ researchers discover some of the oldest forms of life
6. U of M researchers discover new method to combat HIV
7. U of M researchers assess effectiveness of computerized physician order entry system
8. Nepalese researchers identify cost-effective treatment for drug-resistant typhoid
9. Physician-researchers often less successful in obtaining NIH funding
10. UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells
11. Cedars-Sinai researchers present new endocrine findings at 2 international conferences

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/19/2019)... ... , ... Ovation® Fertility scientists have been invited to present four pieces of ... Meeting in Vienna, June 23-26, 2019. , Ovation’s oral presentation about the use ... Science Award for Oral Presentation and the Fertility Society of Australia Exchange Award., ...
(Date:6/18/2019)... PLEASANTON, Calif. (PRWEB) , ... June 18, 2019 ... ... (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced ... designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Aaron ...
(Date:6/16/2019)... ... June 15, 2019 , ... Convoy of Hope continues ... been committed to helping those in need around the world. To date, Convoy has ... 125 countries. Convoy’s work would not be possible without the dedication and generosity of ...
(Date:6/14/2019)... ... June 14, 2019 , ... This past Saturday, volunteers ... their dedicated support staff hosted the Parma Heights Day of Giving, where members of ... the event through local nonprofits that partnered with the Smiles for Everyone Foundation. ...
(Date:6/13/2019)... ... June 13, 2019 , ... ... Second Test (BL30SEC) has been accepted by the 2019 National Conference of Interstate ... N requirements. , The Charm BL30SEC test was validated by third party ...
Breaking Medicine News(10 mins):
(Date:6/16/2019)... ... June 14, 2019 , ... ... analytics platform that helps Life Sciences Manufacturers accurately project their contracted liabilities ... business leaders: accurate, automated forecasting of rebates and discounts and dynamic scenario ...
(Date:6/16/2019)... ... June 15, 2019 , ... Lycotec Ltd, ... a clinical study on its new prebiotic, LycoBiotic™, which is 1,000 – 4,000 ... chocolate formulations, which were based on a proprietary composition of GA lycopene, specially ...
(Date:6/16/2019)... (PRWEB) , ... June 15, 2019 , ... ... afflicts 1.4% of the global population. The condition is characterized by damage ... medical complications including thyroid disease, anemia, osteoporosis, fertility problems and some cancers, to ...
Breaking Medicine Technology:
Cached News: